Evidence map›Paper›PMID 40282849›Full record

ReviewMedicina (Kaunas, Lithuania)2025

Pharmacological Monotherapy for Depressive Disorders: Current and Future-A Narrative Review.

Keming Gao, Evrim Bayrak Oruc, Buket Koparal

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Keming GaoDepartment of Mind and Body Medicine, Sichuan Lansheng Brian Hospital, Chengdu 610036, China.
Evrim Bayrak OrucIndependent Researcher, Cleveland, OH 44113, USA.ORCID 0000-0002-3406-3443
Buket KoparalDepartment of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antidepressive AgentsDepressive DisorderAntidepressive Agents, TricyclicBupropionHumansMajor Depressive DisorderMonoamine Oxidase InhibitorsSelective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake InhibitorsAntidepressive AgentsAntidepressive Agents, TricyclicBupropionMonoamine Oxidase InhibitorsSelective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake Inhibitorsantidepressantsanti-inflammatory agentsbiomarker antidepressant therapydepressive disordersmonotherapyneurosteroid antidepressantsN-methyl-D-aspartate receptor antagonistsopioid receptor antagonistsorexin receptors antagonistspsychedelics

Identifiers

PMID40282849
PMCPMC12028769

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.